NXTC - NextCure, Inc.
12.39
-0.370 -2.986%
Share volume: 80,651
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$12.76
-0.37
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 03-06-2025 | 05-01-2025 | 08-07-2025 | 11-05-2025 | 03-05-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 15.762 M | 16.494 M | 12.495 M | 12.455 M | 11.622 M | 27.292 M | 8.945 M | 9.757 M | |
| Selling general and admin | 4.364 M | 4.076 M | 3.725 M | 3.553 M | 3.726 M | 3.201 M | 2.809 M | 2.957 M | |
| Research and development | 11.398 M | 12.418 M | 8.770 M | 8.902 M | 7.896 M | 24.091 M | 6.136 M | 6.800 M | |
| Total expenses | 18.304 M | 16.494 M | 12.495 M | 12.455 M | 11.622 M | 27.292 M | 8.945 M | 9.757 M | |
| -9.89% | -24.25% | -0.32% | -6.69% | 134.83% | -67.22% | 9.08% | |||
| Operating income | -18.304 M | -16.494 M | -12.495 M | -12.455 M | -11.622 M | -27.292 M | -8.945 M | -9.757 M | |
| Ebit | -17.107 M | -15.404 M | -11.540 M | -11.603 M | -10.976 M | -26.808 M | -8.624 M | -9.436 M | |
| Pretax income | -17.107 M | -15.404 M | -11.540 M | -11.603 M | -10.976 M | -26.808 M | -8.624 M | -9.436 M | |
| -9.95% | -25.08% | 0.55% | -5.40% | 144.24% | -67.83% | 9.42% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -17.107 M | -15.404 M | -11.540 M | -11.603 M | -10.976 M | -26.808 M | -8.624 M | -9.436 M | |
| 9.95% | 25.08% | -0.55% | 5.40% | -144.24% | 67.83% | -9.42% |